Cargando…

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation

BACKGROUND: HeartMate II (HM II) and HeartWare (HW) Left Ventricular Assist Devices have been successfully used in end-stage heart failure patients as a bridge to transplantation, recovery, or decision. We set out to compare their effect in off-loading the left ventricle and its geometry. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Morteza Tavakkoli, Popov, Aron Frederik, Simon, Andre Ruediger, Amrani, Mohamed, Bahrami, Toufan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599225/ https://www.ncbi.nlm.nih.gov/pubmed/23445831 http://dx.doi.org/10.1186/1749-8090-8-31

Ejemplares similares

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke
por: Sabashnikov, Anton, et al.
Publicado: (2013)

Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure
por: Ucar, Mustafa, et al.
Publicado: (2016)

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device
por: Dang, Geetanjali, et al.
Publicado: (2014)

Mitral commissurotomy through the left ventricle apical orifice with Heart Ware left ventricular assist device implantation
por: Mohite, Prashant Nanasaheb, et al.
Publicado: (2013)

Flow dynamics during the HeartWare HVAD to HeartMate 3 exchange: A computational study assessing differential graft lengths and surgical techniques
por: Grinstein, Jonathan, et al.
Publicado: (2022)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device
por: Capoccia, Massimo, et al.
Publicado: (2013)

Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center
por: Esmaeilzadeh, Fatemeh, et al.
Publicado: (2016)

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
por: van den Bergh, Walter M., et al.
Publicado: (2015)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Initial Canadian Experience With Bilateral Minithoracotomy Approach for HeartMate 3 Left Ventricular Assist Device Implantation
por: Vasanthan, Vishnu, et al.
Publicado: (2019)

Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022)

Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022)

Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
por: Damman, Kevin, et al.
Publicado: (2022)

Inflow cannula position as risk factor for stroke in patients with HeartMate 3 left ventricular assist devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2022)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Emergency HeartWare Ventricular Assist Device (HVAD) exchange due to pump thrombosis using minimally invasive technique
por: Antończyk, Remigiusz, et al.
Publicado: (2017)

Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
por: Mahr, Claudius, et al.
Publicado: (2019)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
por: Francica, Alessandra, et al.
Publicado: (2023)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
por: Nguyen Thanh, Hien Kiem, et al.
Publicado: (2015)

Analysis Paralysis: Transition to HeartMate 3 Left Ventricular Assist Device Despite Multiple Complications from COVID-19
por: BhatiaPatel, S., et al.
Publicado: (2022)

Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study
por: Widhalm, Gregor, et al.
Publicado: (2023)

Commentary: Intraoperative cryoblation during HeartMate 3 left ventricular assist device implantation for refractory ventricular arrhythmias: Ipsa scientia potestas est
por: Altshuler, Peter J., et al.
Publicado: (2020)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
por: Francica, Alessandra, et al.
Publicado: (2023)

Design Concepts and Preclinical Results of a Miniaturized HeartWare Platform: The MVAD System
por: Cheung, Anson, et al.
Publicado: (2015)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
por: Imamura, Teruhiko, et al.
Publicado: (2020)

HeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
por: Jang, Mi Young, et al.
Publicado: (2023)

Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)

Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v7darb35u65pc69otn8im3qhk5